The Potential Impacts of Statins and Beta-Blockers on West Virginia Ichthyofauna

Abstract

Pharmaceuticals and personal care products (PPCPs), such as statins and beta-blockers, are commonly used to treat cardiovascular disease in adults. Active versions of these pharmaceuticals and their various metabolites enter surface waters via wastewater treatment plant (WWTP) discharge, as well as from other point sources. Sub-lethal effects of statins and beta-blockers on wild fish at environmental concentrations have been understudied up to this point. The objectives of this study were to use several health condition metrics and determine if there was a relationship between fish condition and environment concentrations of statins and beta-blockers near two West Virginia WWTPs. Water samples were collected from upstream, downstream, and effluent pipe from August to November 2022, and analyzed for atorvastatin, simvastatin, metoprolol, and carvedilol via liquid chromatography with tandem mass spectrometry. Fish were sampled upstream, at the discharge, and downstream of each WWTP in November 2022. Fish health was assessed with three metrics: relative weight (Wr), hepatosomatic index (HSI), and gonadosomatic index (GSI). ANOVAs were used to assess differences among the health metrics based on sex, genus/species, and location relative to WWTPs. Additionally, changes in Wr relative to surface water concentrations of statins and beta-blockers was modeled with a Bayesian linear mixed effects model, with surface water concentrations as fixed effects with a random slope, while the section and genus parameters were treated as random intercepts. Surface concentrations for atorvastatin (0.47–4.36 ng/L), simvastatin (0.27–0.95 ng/L), metoprolol (2.80–21.01 ng/L), and carvedilol (0.43–0.90 ng/L) varied across sampling sections. HSI based on sex and species were nearly significant. GSI was significantly higher in females. Wr differed among genera, as well as the interaction between genus and sample section (p < 0.001). Fixed effects from the linear mixed effects model showed Wr was negatively related to simvastatin (−0.139 [−2.072–1.784]) and carvedilol (−0.262 [−2.164–1.682]) while atorvastatin (0.207 [−1.371–1.845]) and metoprolol (0.052 [−0.533–0.584]) were positively related to Wr. Individual genera responded differently to each pharmaceutical based on location, indicating that it is likely that other factors were also influencing the fish health metrics. Further research targeting individual tissues and controlled experiments with different exposure regimes will be required to further enlighten the long-term effects of cardiovascular PPCPs on fish health.